Investigating how azithromycin affects child health in Burkina Faso
Official title: Heterogeneity of the effect of Azithromycin on morbidity and mortality among children in Burkina Faso
Funded at University of California, San Francisco · NIH-10995089 · Data updated 2026-11-12
This study is looking at how the antibiotic azithromycin can help improve the health of preschool kids in Burkina Faso, especially when used alongside malaria prevention, and it will also consider how things like how far families live from healthcare and their community's wealth might affect how well the treatment works.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 9, 2024 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $42,574 |
| NIH project number | 1F31HD114434-01A1 |
| Project ID | NIH-10995089 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are preschool children aged 0-5 years living in Burkina Faso, particularly those in communities with limited access to healthcare.
✕Less likely to help
Children who are not residing in Burkina Faso or those who do not fall within the preschool age range may not benefit from this research.
What this research studies
This research focuses on understanding the impact of azithromycin, an antibiotic, on the health of preschool children in Burkina Faso. It aims to determine how the combination of azithromycin with seasonal malaria chemoprevention influences child morbidity and mortality rates. The study will also explore how factors like distance to healthcare facilities and community wealth affect the effectiveness of azithromycin treatment. By analyzing these variables, the research seeks to identify the best strategies for administering azithromycin to improve child health outcomes.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies that significantly reduce illness and death among children in Burkina Faso.
How similar studies have gone: Previous studies have shown that mass treatment with antibiotics can effectively reduce infections and mortality in children, suggesting that this approach may yield positive results.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Gebreegziabher, Elisabeth a — University of California, San Francisco
- Study coordinator: Gebreegziabher, Elisabeth a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.